Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Establishment of epidemiological cutoff values against Purpureocillium lilacinum.
Journal: Journal of clinical microbiology
Published: August 21, 2026
Activity of Isavuconazole and Comparator Agents Against Pediatric Isolates From Invasive Fungal Infections.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: February 03, 2026
Antimicrobial Susceptibility of Pseudomonas aeruginosa from Elderly Patients in Intensive Care Units of United States Medical Centers (2021-2025).
Journal: Antibiotics (Basel, Switzerland)
Published: February 02, 2026
Why we do what we do: a survey of ID providers about oral antibiotics.
Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE
Published: January 30, 2026
Multidrug-resistant Enterobacterales in United States hospitals: Frequency and susceptibility to newer β-lactamase inhibitor combinations (2020-2024).
Journal: International journal of antimicrobial agents
Published: November 01, 2025
Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023).
Journal: Antibiotics (Basel, Switzerland)
Published: September 25, 2025
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations.
Journal: JAC-antimicrobial resistance
Published: August 01, 2025
Prospective whole genome sequencing to aid the identification and control of methicillin-susceptible Staphylococcus aureus transmissions in a neonatal ICU.
Journal: The Journal of infection
Published: July 02, 2025
Activity of β-Lactamase Inhibitor Combinations Against Enterobacterales Isolated from Patients with Intra-Abdominal Infection from United States Medical Centres (2019-2023).
Journal: Antibiotics (Basel, Switzerland)
Published: April 25, 2025
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus of diverse genetic types.
Journal: Journal of global antimicrobial resistance
Published: March 26, 2025
Aztreonam/avibactam activity against Enterobacterales from European medical centres: summary of 5 years of surveillance prior to approval for clinical use (2019-2023).
Journal: The Journal of antimicrobial chemotherapy
Published: March 03, 2025
Last Updated: 09/26/2026